[go: up one dir, main page]

ZA836277B - Method for inhibiting mineralization of natural tissue during implantation - Google Patents

Method for inhibiting mineralization of natural tissue during implantation

Info

Publication number
ZA836277B
ZA836277B ZA836277A ZA836277A ZA836277B ZA 836277 B ZA836277 B ZA 836277B ZA 836277 A ZA836277 A ZA 836277A ZA 836277 A ZA836277 A ZA 836277A ZA 836277 B ZA836277 B ZA 836277B
Authority
ZA
South Africa
Prior art keywords
tissue during
during implantation
natural tissue
inhibiting mineralization
mineralization
Prior art date
Application number
ZA836277A
Other languages
English (en)
Inventor
Elisabeth Marie Pollock
David John Lentz
Original Assignee
Extracorporeal Med Spec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Extracorporeal Med Spec filed Critical Extracorporeal Med Spec
Publication of ZA836277B publication Critical patent/ZA836277B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material
    • Y10S623/916—Blood vessel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)
ZA836277A 1982-08-25 1983-08-24 Method for inhibiting mineralization of natural tissue during implantation ZA836277B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/411,191 US4402697A (en) 1982-08-25 1982-08-25 Method for inhibiting mineralization of natural tissue during implantation

Publications (1)

Publication Number Publication Date
ZA836277B true ZA836277B (en) 1985-04-24

Family

ID=23627950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA836277A ZA836277B (en) 1982-08-25 1983-08-24 Method for inhibiting mineralization of natural tissue during implantation

Country Status (7)

Country Link
US (1) US4402697A (xx)
EP (1) EP0103947A3 (xx)
JP (1) JPS5937944A (xx)
BR (1) BR8303581A (xx)
CA (1) CA1200508A (xx)
ES (1) ES525137A0 (xx)
ZA (1) ZA836277B (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215541A (en) * 1982-11-12 1993-06-01 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
EP0126743B1 (en) * 1982-11-12 1989-04-12 BAXTER INTERNATIONAL INC. (a Delaware corporation) Surfactant treatment of implantable biological tissue to inhibit calcification
US4885005A (en) * 1982-11-12 1989-12-05 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US4894063A (en) * 1983-05-24 1990-01-16 Baxter International Inc. Barrier layer for implantable tendons and ligaments
JPS60501396A (ja) * 1983-05-24 1985-08-29 バツクスター　トラベノル　ラボラトリーズ　インコーポレーテツド 移植可能の補綴物のための保護装置
US4753652A (en) * 1984-05-04 1988-06-28 Children's Medical Center Corporation Biomaterial implants which resist calcification
US4553974A (en) * 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US4597766A (en) * 1984-10-26 1986-07-01 American Hospital Supply Corporation Implantable bioprosthetic tendons and ligaments
US4729139A (en) * 1985-11-05 1988-03-08 Baxter Travenol Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
US4770665A (en) * 1985-11-05 1988-09-13 American Hospital Supply Corporation Elastomeric polymer incorporation into implantable biological tissue to inhibit calcification
JPH01500730A (ja) * 1986-08-20 1989-03-16 ザ・チャイルドレンズ・メディカル・センター・コーポレーション 生物学的材料移植片
US4786287A (en) * 1986-10-10 1988-11-22 Baxter Travenol Laboratories Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
US4800603A (en) * 1987-01-30 1989-01-31 Jaffe Norman R Tissue fixation with vapor
JP2529112B2 (ja) * 1987-08-31 1996-08-28 株式会社 高研 生体弁
US5746775A (en) * 1988-04-01 1998-05-05 The Board Of Regent6S Of The University Of Michigan Method of making calcification-resistant bioprosthetic tissue
EP0458877B1 (en) * 1989-02-17 1995-05-17 Baxter International Inc. Calcification mitigation of bioprosthetic implants
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5476516A (en) * 1992-03-13 1995-12-19 Albert Einstein College Of Medicine Of Yeshiva University Anticalcification treatment for aldehyde-tanned biological tissue
US5437287A (en) * 1992-08-17 1995-08-01 Carbomedics, Inc. Sterilization of tissue implants using iodine
US5509932A (en) * 1993-04-08 1996-04-23 Keogh; James R. Fixed tissue medical devices comprising albumin-binding dyes
WO1995024873A1 (en) * 1994-03-14 1995-09-21 Cryolife, Inc. Treated tissue for implantation and preparation methods
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
EP0804255B1 (en) 1994-07-29 2001-10-04 Edwards Lifesciences Corporation Methods for treating implantable biological tissues to mitigate the calcification thereof
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
RU2120212C1 (ru) * 1996-01-16 1998-10-20 Научный центр сердечно-сосудистой хирургии им.А.Н.Бакулева РАМН Способ предимплантационной обработки биологических протезов сосудов и клапанов сердца
US6302909B1 (en) * 1996-07-31 2001-10-16 St. Jude Medical, Inc. Calcification-resistant biomaterials
RU2122321C1 (ru) * 1996-03-06 1998-11-27 Журавлева Ирина Юрьевна Способ обработки биологических протезов для сердечно-сосудистой хирургии
US5782931A (en) * 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
US5891196A (en) * 1997-04-16 1999-04-06 Baxter International Inc. Method for actively binding heparin to crosslinked biological tissues
US5862806A (en) * 1997-10-30 1999-01-26 Mitroflow International, Inc. Borohydride reduction of biological tissues
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6394096B1 (en) 1998-07-15 2002-05-28 Corazon Technologies, Inc. Method and apparatus for treatment of cardiovascular tissue mineralization
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6524339B1 (en) 1999-01-27 2003-02-25 David H. Adams Cryopreserved homografts and other stentless bioprosthetic heart valves having natural tissue sewing rings
US6471723B1 (en) 2000-01-10 2002-10-29 St. Jude Medical, Inc. Biocompatible prosthetic tissue
RU2189142C1 (ru) * 2001-02-19 2002-09-20 Тарасов Юрий Васильевич Способ получения биопротеза для артериальной реконструкции
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US7579381B2 (en) * 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
CN101626682B (zh) 2006-10-27 2014-04-16 爱德华兹生命科学公司 用于外科植入的生物组织
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
EP2549957B1 (en) 2010-03-23 2019-01-30 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
EP2582411B1 (en) 2010-06-17 2019-05-01 Edwards Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
WO2018222434A1 (en) 2017-05-31 2018-12-06 Edwards Lifesciences Corporation Collagen fibers and articles formed therefrom
AU2019212059A1 (en) 2018-01-23 2020-05-21 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
US11103619B2 (en) 2018-08-30 2021-08-31 Efstathios-Andreas AGATHOS Anticalcification treatment for impantable biological tissues using calcitonin
WO2020092205A1 (en) 2018-11-01 2020-05-07 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966401A (en) * 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility
US4050893A (en) * 1974-07-22 1977-09-27 Hancock Laboratories, Inc. Arrangement for preparing natural tissue for implantation
US4323358A (en) * 1981-04-30 1982-04-06 Vascor, Inc. Method for inhibiting mineralization of natural tissue during implantation

Also Published As

Publication number Publication date
EP0103947A2 (en) 1984-03-28
CA1200508A (en) 1986-02-11
JPS5937944A (ja) 1984-03-01
US4402697A (en) 1983-09-06
ES8506455A1 (es) 1985-07-16
BR8303581A (pt) 1984-04-24
ES525137A0 (es) 1985-07-16
EP0103947A3 (en) 1985-03-27

Similar Documents

Publication Publication Date Title
ZA836277B (en) Method for inhibiting mineralization of natural tissue during implantation
ZA836278B (en) Method for inhibiting mineralization of natural tissue during implantation
DE3366423D1 (en) Method of forming implantable prostheses for reconstructive surgery
EP0230672A3 (en) Method for implantation of mammary prosthesis
DE3270910D1 (en) Collagen implant material for augmenting soft tissue
DE3170810D1 (en) Cement for the fixation of bone prostheses
PL236202A1 (en) Method of preventing or retarding mineralization omethod of retarding mineralisation of natural tissf natural tissue during implantation ue during implantation procedures
PH17865A (en) Method of treatment
DE3367296D1 (en) Method of decladding irradiated fuel elements
GB8332450D0 (en) Method of treatment
GB2118043B (en) Femoral prosthesis
DE3363428D1 (en) Method of treating flaxen
SU1121823A1 (ru) Способ получения природных капсаициноидов
BG46924A1 (en) Method for manufacture of bioprothesis of cardiac valve from aortal xenovalves
PL234734A1 (en) Method of feeding of natural hides
BG39891A1 (en) Method for treating stomatitis beneath artificial denture
GB8300362D0 (en) Method of treating body
PL236931A2 (en) Method of improvement of hygienic properties of ready artificial leathers
PL236899A2 (en) Method of improvement of hygienic properties of ready artificial leathers
BG33768A1 (en) Method for treating of oriental tobacco
BG31524A1 (en) Method for operative medical treating of morbid becoming fat
PL245443A1 (en) Method of making surgery implants
BG35205A1 (en) Means for treatment of seborean dermathite
BG33348A1 (en) Method for obtaining of n- aryl- substituated aromatic amidin
PL236969A1 (en) Method of fit-to-eat treating clamary arms